STING1 and cancer: Literature surveys report that STING agonists in combination with chemotherapeutic agents amplify the immune responsive by activating the cascade modulating cancer‐associated fibroblast, perivascular‐like cell state, ferroptosis or cupporoptosis, suppressing the tumour growth.